Teclistamab in patients with multiple myeloma and impaired renal function. | Am J Hematol;98(11): E322-E324, 2023 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Teclistamab in patients with multiple myeloma and impaired renal function.

Joiner, Laura; Bal, Susan; Godby, Kelly N; Costa, Luciano J.

Affiliation

Joiner L; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Bal S; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Godby KN; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Am J Hematol ; 98(11): E322-E324, 2023 Nov.

Article in En | MEDLINE | ID: mdl-37614153

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: Country of publication: